Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.
![](https://perpetuum.bio/wp-content/uploads/2020/08/p-web-blog04-300x188.png)
nutraceuticals
Ombium Launch
Perpetuum launches it’s new brand Ombium, a nutritional supplement line targeting metabolic syndrome risk factors.